Turkmenistan became the first country in Central Asia to officially approve the use of the Russian Sputnik V vaccine, Russian Direct Investment Fund (RDIF) announced in its Monday press release.
According to the press release, the Ministry of Healthcare and Medical Industry of Turkmenistan registered the Russian Sputnik V vaccine against coronavirus.
“Our partners highly appreciated the safety and efficacy of the vaccine, which is one of the world's leading vaccines against coronavirus and has already been approved by regulators in various regions of the world,” RDIF CEO Kirill Dmitriev said in the statement. “Vaccination of the population with the proven Sputnik V vaccine created on a well-researched human adenoviral vectors platform is one of the key elements in preventing the spread of coronavirus.”
Sputnik V vaccine was developed by the National Research Center for Epidemiology and Microbiology named after Honorary Academician N.F. Gamaleya of the Russian Ministry of Health, in partnership with the RDIF.
To date, the Sputnik V vaccine has been approved for use in more than 10 countries around the world.